Financials HC Surgical Specialists Limited
Equities
1B1
SG1DC2000004
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 SGD | 0.00% | 0.00% | -13.33% |
Jan. 12 | Singapore Shares End Week in Red; Totm Technologies Shares Rise 9% Despite Wider Fiscal H1 Loss | MT |
Jan. 12 | HC Surgical Specialists' Attributable Profit Zooms 68% in Fiscal H1 | MT |
Valuation
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 102.2 | 83.33 | 45.92 | 71.47 | 69.98 | 59.56 |
Enterprise Value (EV) 1 | 99.31 | 78.66 | 46.7 | 68.35 | 69.07 | 54.52 |
P/E ratio | 22.9 x | 11.6 x | 13.1 x | 9 x | 11 x | 20.4 x |
Yield | 3.07% | 3.93% | 6.56% | 8.33% | 5.53% | 5% |
Capitalization / Revenue | 6.38 x | 4.55 x | 2.72 x | 3.05 x | 3.6 x | 3.07 x |
EV / Revenue | 6.2 x | 4.29 x | 2.77 x | 2.91 x | 3.56 x | 2.81 x |
EV / EBITDA | 17 x | 12.1 x | 7.48 x | 7.05 x | 9.56 x | 8.34 x |
EV / FCF | 23.4 x | 17.3 x | 14.6 x | 9.31 x | 10.1 x | 6.89 x |
FCF Yield | 4.27% | 5.8% | 6.85% | 10.7% | 9.87% | 14.5% |
Price to Book | 6.12 x | 4.19 x | 2.82 x | 7.27 x | 6.36 x | 4.92 x |
Nbr of stocks (in thousands) | 149,176 | 148,806 | 150,566 | 148,892 | 148,892 | 148,892 |
Reference price 2 | 0.6850 | 0.5600 | 0.3050 | 0.4800 | 0.4700 | 0.4000 |
Announcement Date | 9/11/18 | 9/10/19 | 9/6/20 | 9/5/21 | 9/4/22 | 9/10/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Mei | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 16.02 | 18.32 | 16.89 | 23.47 | 19.42 | 19.4 |
EBITDA 1 | 5.84 | 6.503 | 6.241 | 9.691 | 7.223 | 6.539 |
EBIT 1 | 5.49 | 6.088 | 5.815 | 9.199 | 6.718 | 6.099 |
Operating Margin | 34.27% | 33.24% | 34.44% | 39.2% | 34.59% | 31.43% |
Earnings before Tax (EBT) 1 | 6.067 | 9.444 | 4.823 | 10.27 | 7.747 | 4.053 |
Net income 1 | 4.464 | 7.206 | 3.498 | 8 | 6.38 | 2.919 |
Net margin | 27.86% | 39.34% | 20.72% | 34.09% | 32.85% | 15.04% |
EPS 2 | 0.0299 | 0.0483 | 0.0233 | 0.0533 | 0.0428 | 0.0196 |
Free Cash Flow 1 | 4.242 | 4.559 | 3.198 | 7.34 | 6.818 | 7.91 |
FCF margin | 26.48% | 24.89% | 18.94% | 31.28% | 35.11% | 40.76% |
FCF Conversion (EBITDA) | 72.65% | 70.11% | 51.25% | 75.74% | 94.39% | 120.97% |
FCF Conversion (Net income) | 95.04% | 63.27% | 91.44% | 91.75% | 106.86% | 271% |
Dividend per Share 2 | 0.0210 | 0.0220 | 0.0200 | 0.0400 | 0.0260 | 0.0200 |
Announcement Date | 9/11/18 | 9/10/19 | 9/6/20 | 9/5/21 | 9/4/22 | 9/10/23 |
Balance Sheet Analysis
Fiscal Period: May | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 0.77 | - | - | - |
Net Cash position 1 | 2.88 | 4.68 | - | 3.12 | 0.91 | 5.03 |
Leverage (Debt/EBITDA) | - | - | 0.124 x | - | - | - |
Free Cash Flow 1 | 4.24 | 4.56 | 3.2 | 7.34 | 6.82 | 7.91 |
ROE (net income / shareholders' equity) | 35.5% | 45.1% | 21.9% | 64.9% | 61.9% | 25.6% |
ROA (Net income/ Total Assets) | 18% | 15.5% | 12.7% | 17.2% | 12.5% | 12.3% |
Assets 1 | 24.85 | 46.64 | 27.44 | 46.39 | 51.09 | 23.82 |
Book Value Per Share 2 | 0.1100 | 0.1300 | 0.1100 | 0.0700 | 0.0700 | 0.0800 |
Cash Flow per Share 2 | 0.0300 | 0.0300 | 0.0500 | 0.0700 | 0.0500 | 0.0400 |
Capex 1 | 0.26 | 0.3 | 1.27 | 0.51 | 0.22 | 0.71 |
Capex / Sales | 1.6% | 1.61% | 7.51% | 2.18% | 1.13% | 3.64% |
Announcement Date | 9/11/18 | 9/10/19 | 9/6/20 | 9/5/21 | 9/4/22 | 9/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-13.33% | 29.35M | |
-14.66% | 84.68B | |
+14.53% | 81.12B | |
+10.49% | 29.59B | |
-9.38% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+31.62% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- 1B1 Stock
- Financials HC Surgical Specialists Limited